Advertisement

Apoptosis

pp 1–9 | Cite as

Activator protein-1 and caspase 8 mediate p38α MAPK-dependent cardiomyocyte apoptosis induced by palmitic acid

  • Charles C. OhEmail author
  • John Lee
  • Karen D’Souza
  • Weiyang Zhang
  • Raymond Q. Migrino
  • Kent Thornburg
  • Peter Reaven
Short Communication
  • 15 Downloads

Abstract

Lipoapoptosis of cardiomyocytes may underlie diabetic cardiomyopathy. Numerous forms of cardiomyopathies share a common end-pathway in which apoptotic loss of cardiomyocytes is mediated by p38α mitogen activated protein kinase (MAPK). Although we have previously shown that palmitic acid (PA), a saturated fatty acid (SFA) elevated in plasma of type 2 diabetes mellitus and morbid obesity, induces apoptosis in cardiomyocytes via p38α MAPK-dependent signaling, the downstream cascade events that cause cell death remain unknown. The objective of this study was to investigate mechanisms involved in palmitic acid-induced cardiomyocyte apoptosis. Human adult ventricular cardiomyocyte line (AC16 cells) exposed to high physiological levels of PA for 16 h showed enhanced transcription and phosphorylation of c-fos and c-jun subunits of AP-1 and transcription of caspase 8. When AC16 cells were transfected with small interfering RNA specific against p38α MAPK (si-p38α) for 24 or 48 h, the amplified phosphorylation of c-fos was dose-dependently attenuated, and procaspase 8 was dose-dependently reduced. With translational knockdown of c-fos, PA-induced apoptosis was diminished. Inhibition of caspase 8 for 24 h reduced apoptosis in PA-treated cardiomyocytes. These findings provide evidence for induction of apoptosis in cardiomyocytes exposed to high SFA by a novel pathway requiring activation of c-fos/AP-1 and caspase 8. These results demonstrate how elevated plasma SFA may lead to continual and cumulative loss of cardiomyocytes and potentially contribute to the development of diabetic cardiomyopathy.

Keywords

P38α AP-1 Caspase 8 Apoptosis Diabetic cardiomyopathy 

Notes

Funding

This work has been funded by VA VISN 18 New Investigator Grant (to C.O.), CSR&D 5I01CX000598 grant (to P.R.), and VA Merit Grant BLRD I01BX007080 (to R.M.). The study was supported by VA Employment and Carl T. Hayden Medical Research Foundation. The contents and the views do not represent the views of the Department of Veterans Affairs or the US government. K.T. is supported by the M. Lowell Edwards Endowment.

Compliance with ethical standards

Disclosures

We have no disclosures to make.

Supplementary material

10495_2018_1510_MOESM1_ESM.docx (8.3 mb)
Supplementary material 1 (DOCX 8456 KB)

References

  1. 1.
    Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr (2004) Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27:699–703CrossRefGoogle Scholar
  2. 2.
    Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213–3223CrossRefGoogle Scholar
  3. 3.
    Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM (1985) Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 61:807–811CrossRefGoogle Scholar
  4. 4.
    Oh CC, Nguy MQ, Schwenke DC, Migrino RQ, Thornburg K, Reaven P (2014) p38alpha mitogen-activated kinase mediates cardiomyocyte apoptosis induced by palmitate. Biochem Biophys Res Commun 450:628–633CrossRefGoogle Scholar
  5. 5.
    Bell DS (2003) Diabetic cardiomyopathy. Diabetes Care 26:2949–2951CrossRefGoogle Scholar
  6. 6.
    Schwartz EA, Zhang WY, Karnik SK et al (2010) Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler Thromb Vasc Biol 30:802–808CrossRefGoogle Scholar
  7. 7.
    Szczepaniak LS, Victor RG, Orci L, Unger RH (2007) Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 101:759–767CrossRefGoogle Scholar
  8. 8.
    Kang YJ, Zhou ZX, Wang GW, Buridi A, Klein JB (2000) Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J Biol Chem 275:13690–13698CrossRefGoogle Scholar
  9. 9.
    Shi J, Guan J, Jiang B et al (2010) Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci USA 107:4188–4193CrossRefGoogle Scholar
  10. 10.
    Alpert MA, Lambert CR, Panayiotou H et al (1995) Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 76:1194–1197CrossRefGoogle Scholar
  11. 11.
    Sari FR, Widyantoro B, Thandavarayan RA et al (2011) Attenuation of CHOP-mediated myocardial apoptosis in pressure-overloaded dominant negative p38alpha mitogen-activated protein kinase mice. Cell Physiol Biochem 27:487–496Google Scholar
  12. 12.
    Tanos T, Marinissen MJ, Leskow FC et al (2005) Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J Biol Chem 280:18842–18852CrossRefGoogle Scholar
  13. 13.
    Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072:129–157Google Scholar
  14. 14.
    Yoon CH, Kim MJ, Park MT et al (2009) Activation of p38 mitogen-activated protein kinase is required for death receptor-independent caspase-8 activation and cell death in response to sphingosine. Mol Cancer Res: MCR 7:361–370CrossRefGoogle Scholar
  15. 15.
    El Mchichi B, Hadji A, Vazquez A, Leca G (2007) p38 MAPK and MSK1 mediate caspase-8 activation in manganese-induced mitochondria-dependent cell death. Cell Death Differ 14:1826–1836CrossRefGoogle Scholar
  16. 16.
    Liedtke C, Lambertz D, Schnepel N, Trautwein C (2007) Molecular mechanism of Mitomycin C-dependent caspase-8 regulation: implications for apoptosis and synergism with interferon-alpha signalling. Apoptosis 12:2259–2270CrossRefGoogle Scholar
  17. 17.
    Tourian L Jr, Zhao H, Srikant CB (2004) p38alpha, but not p38beta, inhibits the phosphorylation and presence of c-FLIPS in DISC to potentiate Fas-mediated caspase-8 activation and type I apoptotic signaling. J Cell Sci 117:6459–6471CrossRefGoogle Scholar
  18. 18.
    Salvesen GS, Walsh CM (2014) Functions of caspase 8: the identified and the mysterious. Semin Immunol 26:246–252CrossRefGoogle Scholar
  19. 19.
    Derijard B, Hibi M, Wu IH et al (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025–1037CrossRefGoogle Scholar
  20. 20.
    Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW (1990) Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci USA 87:5663–5666CrossRefGoogle Scholar
  21. 21.
    Devary Y, Gottlieb RA, Lau LF, Karin M (1991) Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 11:2804–2811CrossRefGoogle Scholar
  22. 22.
    Brandt B, Abou-Eladab EF, Tiedge M, Walzel H (2011) Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death. Cell Death Dis 1:e23CrossRefGoogle Scholar
  23. 23.
    Shin JH, Jeong JY, Jin Y, Kim ID, Lee JK (2011) p38beta MAPK affords cytoprotection against oxidative stress-induced astrocyte apoptosis via induction of alphaB-crystallin and its anti-apoptotic function. Neurosci Lett 501:132–137CrossRefGoogle Scholar
  24. 24.
    Guo YL, Kang B, Han J, Williamson JR (2001) p38beta MAP kinase protects rat mesangial cells from TNF-alpha-induced apoptosis. J Cell Biochem 82:556–565CrossRefGoogle Scholar
  25. 25.
    Thandavarayan RA, Watanabe K, Ma M et al (2009) Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus. Am J Physiol Heart Circ Physiol 297:H911–H919CrossRefGoogle Scholar
  26. 26.
    Yuan H, Zhang X, Huang X et al (2010) NADPH oxidase 2-derived reactive oxygen species mediate FFAs-induced dysfunction and apoptosis of beta-cells via JNK, p38 MAPK and p53 pathways. PLoS ONE 5:e15726CrossRefGoogle Scholar
  27. 27.
    Gilley R, March HN, Cook SJ (2009) ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos. Cell Signal 21:969–977CrossRefGoogle Scholar
  28. 28.
    Portal MM, Ferrero GO, Caputto BL (2007) N-Terminal c-Fos tyrosine phosphorylation regulates c-Fos/ER association and c-Fos-dependent phospholipid synthesis activation. Oncogene 26:3551–3558CrossRefGoogle Scholar
  29. 29.
    Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4:556–564CrossRefGoogle Scholar
  30. 30.
    Lee JYSK, Rhee SH, Hwang D (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276:16683–16689CrossRefGoogle Scholar
  31. 31.
    Lee JY, Zhao L, Youn HS et al (2004) Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 279:16971–16979CrossRefGoogle Scholar
  32. 32.
    Zhang J, Zhang H, Deng X, Zhang Y, Xu K (2017) Baicalin protects AML-12 cells from lipotoxicity via the suppression of ER stress and TXNIP/NLRP3 inflammasome activation. Chem Biol Interact 278:189–196CrossRefGoogle Scholar
  33. 33.
    Ding C, Zhao Y, Shi X et al (2016) New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats. Sci Rep 6:28734CrossRefGoogle Scholar
  34. 34.
    Zhang Y, Miao LS, Cai YM et al (2018) TXNIP knockdown alleviates hepatocyte ischemia reperfusion injury through preventing p38/JNK pathway activation. Biochem Biophys Res Commun 502:409–414CrossRefGoogle Scholar
  35. 35.
    Jung H, Kim DO, Byun JE et al (2016) Thioredoxin-interacting protein regulates haematopoietic stem cell ageing and rejuvenation by inhibiting p38 kinase activity. Nat Commun 7:13674CrossRefGoogle Scholar
  36. 36.
    Sun Q, Xu H, Xue J et al (2018) MALAT1 via microRNA-17 regulation of insulin transcription is involved in the dysfunction of pancreatic beta-cells induced by cigarette smoke extract. J Cell Physiol 233:8862–8873CrossRefGoogle Scholar
  37. 37.
    Huang S, Rutkowsky JM, Snodgrass RG et al (2012) Saturated fatty acids activate TLR-mediated pro-inflammatory signaling pathways. J Lipid Res.  https://doi.org/10.1194/jlr.D029546 Google Scholar
  38. 38.
    Miura K, Yang L, van Rooijen N, Brenner DA, Ohnishi H, Seki E (2012) TLR2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation. Hepatology 57(2):577–589Google Scholar
  39. 39.
    Wang Y, Qian Y, Fang Q et al (2017) Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat Commun 8:13997CrossRefGoogle Scholar
  40. 40.
    Tian H, Liu C, Zou X, Wu W, Zhang C, Yuan D (2015) MiRNA-194 regulates palmitic acid-induced toll-like receptor 4 inflammatory responses in THP-1 cells. Nutrients 7:3483–3496CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Cardiology DivisionPhoenix VA Healthcare SystemPhoenixUSA
  2. 2.Norton Thoracic InstitutePhoenixUSA
  3. 3.Carl T Hayden Research FoundationPhoenixUSA
  4. 4.Oregon Health and Science UniversityPortlandUSA
  5. 5.Phoenix VA Healthcare SystemPhoenixUSA

Personalised recommendations